Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sleeping through Menopause
NL-OMON60796Phase 4Recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of progesterone in Insomnia and menopause (3 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Change in insomnia severity. Started Oct 2025; status: recruiting.
02
Drugs
progesterone
03
Conditions
Insomniamenopause
Beyond the preview
Go deeper on NL-OMON60796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60796.